key: cord-0860165-be4dq3uk
authors: Önder Tokuç, Ecem; Karabaş, V. Levent; Şermet, Figen
title: Survey of Intravitreal Injection Techniques and Treatment Protocols Among Members of the Turkish Ophthalmological Association
date: 2021-12-28
journal: Turk J Ophthalmol
DOI: 10.4274/tjo.galenos.2021.18794
sha: 751de4cb8c074c42129f0f10226a3fbc1f551dbe
doc_id: 860165
cord_uid: be4dq3uk

OBJECTIVES: To describe the intravitreal injection (IVI) techniques, practices, and treatment protocols of ophthalmologists in Turkey from May 20, 2020 to June 4, 2020. MATERIALS AND METHODS: All members of the Turkish Ophthalmological Association were contacted by e-mail to complete an anonymous, 47-question internet-based survey. RESULTS: Thirteen percent of the participants prescribed prophylactic antibiotics pre-injection, 63.8% (406/636) used antibiotic drops immediately after injection, and 91.8% prescribed topical antibiotics. The majority of IVI procedures were performed in an operating room (65.3%) or clean room (33.6%). Most surgeons used sterile gloves, masks, sterile drape, sterile fenestrated cover, and sterile eyelid speculum. Multispecialists (M) preferred to wear sterile gloves more than retina specialists (RS) (99.0% vs. 95.3%; p=0.004). Also, M prescribed antibiotics more than RS (93.7% vs. 88.8%; p=0.029). RS dilated the pupil more frequently than M (48.3% vs. 39.0%) (p=0.020). RS were more familiar to use different quadrants (right p=0.012; left p=0.001). Most surgeons (82.8%) did not perform injections in both eyes on the same day. CONCLUSION: Ophthalmologists in Turkey employ a wide range of techniques in care before, during, and after IVI. In addition, IVI techniques and treatment protocols differed between RS and M. Further research is needed to elucidate best practice patterns.

Intravitreal injections (IVI) are widely used by ophthalmologists for the treatment of various retinal diseases. The IVI technique was first described in 1911 and has been used to administer anti-vascular endothelial growth factors, corticosteroids, and other drugs for many years. 1, 2 There are several published guidelines describing the indications and procedures of IVI. 3, 4, 5 However, there is no consensus among clinicians on the intravitreal injection technique or pre-injection and post-injection care.

The aim of this study was to determine the personal preferences of ophthalmologists in Turkey regarding IVI procedures.

All members of the Turkish Ophthalmological Association were contacted via e-mail in May 2020 to complete a 47-question internet-based survey. Three reminder e-mails were sent to the participants who had not completed the survey. SurveyMonkey (www.surveymonkey.com; SurveyMonkey, San Mateo, CA) was used for the data collection. The final results were collected on June 4, 2020. Thirty-five questions related to injection and follow-up procedures were evaluated. In the first 3 questions, participants were asked about demographic data (institution, society membership). The fourth question asked if the participant had experience with IVI. Participants who did not have any experience with IVI were directed to the end of the questionnaire. Reimbursement regulations in Turkey indicate 3 consecutive monthly injections of bevacizumab for the treatment of diabetic macular edema (DME), agerelated macular degeneration (AMD), and retinal vein occlusion. Therefore, there was no question about the timing of IVI in the survey. Protocol differences regarding the injection techniques were also evaluated. Participants were divided into the retina specialist-only group (RS) and multispecialty group (M) and protocol differences were compared between groups.

All P values were derived from chi-square tests using SPSS software version 20 (IBM Corp, Armonk, NY). The research protocol was initially submitted to the Institutional Ethics Committee and Review Board of the University of Kocaeli (registration number: KAEK 2020/219).

A total of 892 ophthalmologists answered the questionnaire. Of these, 232 participants reported having no experience related to IVI. The other 660 participants who were actively performing IVI were included in our analysis of practice patterns.

The participants' institutions are presented in Table 1 Nearly all participants (97.5%, 630/646) wore sterile gloves during IVI. The use of sterile gloves was higher in M (99.0%) than RS (95.3%) (p=0.004). Similarly, nearly all participants wore masks (98.3%). Eighty-one percent (523/646) of the participants said they cover their noses with the mask and all stated the importance of covering the nose. In addition, 72.4% (467/645) of the participants wore special surgical clothes. There was no difference between RS and M in terms of mask use (96.9% vs. 99.2%, respectively) (p=0.087) or the use of special surgical clothes (68.5% vs. 75.1%, respectively) (p=0.065).

Most surgeons (82.8%, 535/646) did not perform injections in both eyes on the same day. RS preferred same-day bilateral injection more frequently than M (21.8% vs. 14.2%, p=0.013). Most of the surgeons who performed bilateral same-day injections used a sequential procedure (79.6%, 86/108). There was no significant difference in sequential procedure use between RS and M (85.5% vs. 73.6%) (p=0.126). Pupil dilation before IVI was practiced by 42.7% of participants overall (276/646) and was significantly more common among RS than M (48.3% vs. 39.0%) (p=0.020).

The most common quadrant for right eye injection was the superotemporal quadrant (78.5%, 499/636) followed by the inferotemporal ( When performing injections, 70.9% (449/633) of the participants said they hold the needle perpendicular to the globe. The tendency to use this needle position was higher in M than RS (74.0% vs. 66.4%, respectively, p=0.039).

Most participants (93.1%, 591/632) did not use indirect ophthalmoscopy to evaluate retinal and optic nerve perfusion after injection. There was no significant difference in the use of indirect ophthalmoscopy between RS and M (5.6% vs. 7.9%, respectively, p=0.091).

Evaluation for central retinal artery occlusion (CRAO) after injection was performed using hand motion and finger counting by 42.5% (270/636) of participants and with light perception assessment by 17 Approximately half of the surgeons assumed that patients with AMD receive 6-7 injections per year, while this number was assumed to be 1-3, 4-5, and 8 or more by 6.2%, 33.9%, and 11.3% of participants, respectively. More RS than M assumed 6-7 injections yearly for AMD (60.2% vs. 40.5%, p=0.000).

For patients with DME, 42%, 38%, 11%, and 9% of participants assumed 6-7, 1-3, 4-5, and 8 or more injections per year, respectively. More RS than M assumed 6-7 injections for DME (49.4% vs. 36.5%, p=0.002).

Several guidelines for intravitreal drug injections have been published in recent years. 6, 7 However, pre-injection preparation, injection technique, and post-injection care preferences vary in daily practice. In this study, we report the preferred IVI techniques of surgeons in Turkey.

Most participants did not use prophylactic antibiotics before IVI. Similarly, 76.8% of members of the American Society of Retina Specialists (ASRS) did not prescribe pre-injection antibiotics in a 2018 survey. 8 A report of the American Academy of Ophthalmology in 2014 stated that there is insufficient evidence supporting the use of prophylactic antibiotics to reduce the risk of endophthalmitis. 9 According to a EURETINA expert consensus report in 2018, perioperative antibiotic use was also not considered standard care. 6 Furthermore, recent studies suggest that antibiotic prophylaxis may lead to antibiotic resistance. 10, 11 Almost two-thirds (63.8%) of our respondents used topical antibiotic drops immediately after injection. In contrast, the rate of antibiotic use always or frequently immediately after injection was limited to 16.6% in the recent ASRS survey. 8 In our survey, the rate of prescribing antibiotics for home use was very high at 91.8%. In the ASRS survey, this rate was 33%. Antibiotics were prescribed for home use more frequently and for longer duration by the multispecialty group than the retina specialist group. This may be related to retina specialists' ability to manage complications that may occur after IVI.

Guidelines do not recommend perioperative antibiotics. 3,6 However, in the real world, 33% of ASRS members prescribed antibiotics after injections. This may be due to a lack of trust in guideline recommendations. Usage rates among Turkish surgeons were also higher than elsewhere in the world. This is associated with surgeons' reluctance to take risks and to avoid malpractice allegations.

Nearly all (91.65%) of the surgeons used a sterile drape. This rate is much higher than ASRS 2018 data (10.9%). Studies suggest that sterile covers isolate the mouth and nose of patients and may reduce patient-induced transmission. 12, 13 However, the EURETINA 2018 consensus report noted that there is not enough evidence to reduce the risk of postoperative infection using sterile drapes, and they can be used according to surgeon preference. 14 Most of the participants wore masks (98.30%) and sterile gloves (97.52%) before the procedure. In the ASRS survey 2018 data, only 32.9% of the participants wore masks and 54.8% wore gloves (50.4% sterile gloves). Forty-one percent of salivary isolates constitute Streptococcus species 15 and post-IVI endophthalmitis are mostly caused by streptococci. 16, 17 Production of oropharyngeal droplets is thought to cause contamination of the sterile infection site. 15 Studies show that wearing a mask during injection and adopting a "no talking" policy significantly reduces the formation of bacterial colonies on culture plates. 18 The EURETINA 2018 consensus report recommended wearing a mask. 6 Most of the participants in our study (81.0%) also preferred to cover the nose while wearing a mask. It was especially emphasized that the use of effective masks or respirators (covering both the mouth and nose) during the COVID-19 pandemic is effective in preventing aerosol formation and transmission. 19 Interestingly, the rate of wearing sterile gloves was lower in the retina specialist group. This may also be related to retina specialists' higher level of confidence regarding the management of complications such as endophthalmitis. The World Health Organization's hand hygiene guideline recommends hand hygiene and wearing gloves before surgical interventions. 20 However, no study has directly evaluated the effect of sterile or non-sterile gloves and surgical hand washing before IVI in reducing the risk of endophthalmitis.

The vitreous is a rich medium for low-virulence bacteria and has immune privilege. Therefore, we believe that IVI should be considered an aseptic procedure.

In the presented survey, the most commonly used anesthesia was topical drops (97.8%). Consistent with our results, Canadian retina specialists and ASRS members also preferred topical drops before injection. 8, 21 Although there is a lack of evidence regarding the anesthesia technique before IVI, topical anesthesia is recommended because it is the least invasive anesthesia method.

Nearly all of our participants (96%) used a sterile eyelid speculum. This was similar to the preferences of Canadian surgeons (91%). 21 During IVI it is necessary to prevent involuntary closure of the lids and needle contamination by the eyelashes. An increase in the rate of endophthalmitis was reported when adequate lid retraction was not achieved. 22 In the 2018 ASRS survey, 73% of all members used an eyelid speculum, which showed a decline from 92% in 2011. This was associated with the more frequent use of bimanual retraction technique. 23

Nearly all (98.9%) surgeons used PI antisepsis in the conjunctiva. This rate was similar to those reported in Canada, ASRS members (92.2%), and the United Kingdom. 8, 21, 24 Most of the surgeons (71.9%) preferred to use a 5% PI solution. PI has broad-spectrum microbicidal activity and is important for antisepsis. It reduces the pathogen load on the ocular surface prior to the surgical procedure and its use on the conjunctiva and periocular skin before IVI is strongly recommended. 20, 25 In order to achieve a bactericidal effect at PI concentrations in this range, it is necessary to wait 30-120 seconds after a single application, and a single application is sufficient. 25 The 2018 EURETINA consensus report suggested using 5% PI for 30 seconds before IVI. 6

The preferred setting for IVI was an operating room for 65.3% of the surgeons and a clean room for 33.6% of the surgeons. In contrast, IVIs are performed mainly as an office procedure in the United States and Canada, with a low incidence of post-injection endophthalmitis. A previous study indicated no significant difference between the office and operating room in terms of the incidence of endophthalmitis in IVIs. 26 In the 2018 EURETINA report, IVIs were reported to have similar risk in terms of infection frequency. 6

Most surgeons preferred the superotemporal quadrant (78.5% in the right eye, 68.2% in the right eye), followed by the inferotemporal quadrant (18.2% right, 17.3% left). In contrast, the inferotemporal quadrant was preferred by a majority of Canadian retina specialists (63%) and ASRS members (61.8% right, 61.0% left). Recent guidelines leave the choice of injection quadrant to the surgeon's preference. 14 An advantage of performing IVI in the inferotemporal quadrant may be that it prevents the drug from interfering with the patient's vision. Conversely, if retinal detachment occurs after injection, the superotemporal quadrant may be more advantageous for pneumatic retinopexy. The retina specialists in our study are more familiar with using different quadrants because of their vitreoretinal surgery experience, and therefore may choose each quadrant separately.

Approximately 70% of the participants held the needle perpendicular to the globe. This method has been preferred by most surgeons for many years. However, recent studies indicate that the tunnel technique is superior in the prevention of vitreous reflux. 27 The tunnel technique involves inserting the needle at a 30 degree angle to the globe, then raising it perpendicular to the center. This approach may prevent trapping of the vitreous in the sclera, which is called vitreous wick syndrome, and/or bacterial entry into the vitreous.

More than half (58.0%) of the participants stated that they were not able to administer the injection on the same day they decided on the treatment. The rate of same day injection was higher in the retina specialist group. This may be explained by the fact that retina specialists have more experience with IVI.

In our study, 64.5% of the participants stated that they examined the patients monthly and followed up with a PRN regimen after the first 3 injections for AMD. Another 33.6% of the participants said they followed a TREX regimen, treating monthly until patients' eye were dry and then extending the treatment interval at subsequent visits. Recent studies have confirmed that the TREX regimen maintains or improves visual acuity in patients with AMD. 28, 29 The number of examinations each year is lower in the TREX protocol than in the PRN protocol. 28 Studies indicate that the longer treatment intervals in the TREX protocol reduce patient anxiety. 28 Unlike American surgeons, our survey results demonstrate low usage of the TREX protocol for AMD in Turkey Many surgeons in our study estimated that patients with AMD and DME require 6-7 injections per year. However, different results were obtained in real-life case studies in Turkey for AMD. The Bosphorus Retina Study Group stated in a reallife study conducted between 2013 and 2014 that the average annual number of injections was 4.1 for AMD. 30, 31 This suggests that the annual number of injections estimated by surgeons is not consistent with real-life practice.

Most of the participants preferred not to inject both eyes in the same appointment (82.8%). However, this rate differed in North America, as 71.5% of ASRS members and 57% of Canadian retina specialists were reported to prefer bilateral injection on the same day. 8, 21 Recent studies suggest that bilateral IVI does not increase the rate of adverse events compared to unilateral injections. 32, 33 The latest EURETINA guideline recommends same-day bilateral injection using separate equipment for each eye (sequential injections). 6 The lower preference for same-day bilateral injections among ophthalmologists in Turkey may be related to the obligatory application of an initial 3 consecutive monthly injections of bevacizumab due to reimbursement regulations. In addition, dispensing multiple syringes from a single bevacizumab bottle may increase the risk of endophthalmitis.

Only 57.3% of the participants dilated the pupil before injection. This rate was much lower than Canadian retinal specialists (83%). 21 There is currently no consensus to widen pupil before IVI. The 2018 EURETINA guideline states that the decision for pupil dilation before IVI depends on the practitioner. This guideline recommends pupil dilation for physicians who are newly performing IVI to enable immediate examination of retinal and optic nerve perfusion. In contrast, retina specialists preferred to dilate the pupil more frequently than multispecialists in our survey.

Over two-thirds (67.2%) of the surgeons evaluated retinal and optic nerve perfusion immediately after the injection. This rate was higher than in the ASRS survey (56.0%). It is known that a short-term increase in intraocular pressure occurs after IVI. 34 Visual acuity test (finger counting or hand movement test), intraocular pressure measurement, or direct visualization of the optic nerve can be performed to assess ischemic optic nerve damage and check for perfusion. Although light perception indicates the presence of central retinal artery perfusion, the most reliable method of ensuring arterial perfusion is direct imaging. 34, 35 Almost half of the surgeons (47.6%) reported performing clinical examination on postoperative day 1, whereas 31.6% did not perform an examination. Most surgeons (81.1%) who did not prefer clinical examination verbally informed the patients about potential complications, and a smaller group (11.7%) said they used an information form. In recent years, telephone contact has been more commonly used for the follow-up and reporting of complications after IVI. 35 According to a United States expert panel from 2014, patients should be informed before discharge about the symptoms of possible post-injection complications such as endophthalmitis, retinal detachment, and intraocular hemorrhage, and 24-hour contact information should be provided to the patient. 14

In this study, the response rate was 90% and our results showed that ophthalmologists in Turkey have varying preferences regarding IVI techniques. Furthermore, their practices differ in some ways from those of Canadian surgeons and ASRS members. In many countries, IVI is considered a surgical procedure and is performed in an operating room. In the United States, IVI is performed as an office-based procedure to reduce costs and accommodate the large number of patients. Office-based procedures are generally performed in the examination room without using a sterile drape, sterile gloves, sterile surgical clothes, or mask. The results of our survey are more similar to European surgeon practices. 36 The results of this study are generally compatible with IVI guidelines, except for the high rate of postoperative antibiotic prescription and performing bilateral intravitreal injections on the same day.

IVI are generally administered only by retina specialists around the world, which differs from the practice of surgeons in Turkey. Current healthcare practices allow IVI to be performed not only by retina specialists, but also by other ophthalmologists. This may lead to differences in IVI practices of our country. These discrepancies should be considered when performing retrospective studies to examine the efficacy and safety of IVI. More evidence-based medicine is required to identify IVI techniques that combine safety and efficacy.

Über die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flüssigkeit und Einspritzen vom Luft in den Glaskörper

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

Evolving guidelines for intravitreous injections

Recommendations for carrying out intravitreal injections

Evolving intravitreous injection technique

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline

Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents

Survey of intravitreal injection techniques among retinal specialists in the United States

Post-Injection Endophthalmitis Study Team. The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection

Topical antibiotics and intravitreal injections

Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study

Bacterial dispersal associated with speech in the setting of intravitreous injections

Intravitreal injection technique and monitoring: updated guidelines of an expert panel

Indigenous flora from human saliva

Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies

Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study

Reducing oral flora contamination of intravitreal injections with face mask or silence

COVID-19: The Need for Rational Use of Face Masks in Nigeria

Increased bactericidal activity of dilute preparations of povidone-iodine solutions

Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada

Collaborative Anti-VEGF Ocular Vascular Complications Group: Insight into 144 patients with ocular vascular events during VEGF antagonist injections

Speculum versus bimanual lid retraction during intravitreal injection

National survey of the technique of intravitreal triamcinolone injection in the United Kingdom

Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics

Endophthalmitis associated with intravitreal injections: officebased setting and operating room setting

Tunnelled versus straight intravitreal injection: Intraocular pressure changes, vitreous reflux, and patient discomfort

Prospective Trial of Treatand-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: TREX-AMD 1-Year Results

Randomized Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: 2-Year Results of the TREX-AMD Study

Yılmazabdurrahmanoğlu Z; Bosphorus Retina Study Group. Comparison of two different treatment regimens' efficacy in neovascular age-related macular degeneration in Turkish population-based on real life data-Bosphorus RWE Study Group

Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study

Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections

Same-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center

Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents

Intravitreal injection technique

Practice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal survey

Acknowledgements: The authors express their appreciation to Turkish Ophthalmological Association for their support.

Financial Disclosure: The authors declared that this study received no financial support.